Tetrakis(4-(1H-imidazol-1-yl)phenyl)methane, 97%, 5g

1-Pyrrolidin-3-yl-1H-pyrazole dihydrochloride, 95.0%, 1g

4-Aminomethylphenylboronic acid hydrochloride, 98.0%, 250mg

5-oxo-5-(9-Phenanthryl)valeric acid, 97.0%, 1g

L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-[(4-methylphenyl)diphenylmethyl]-, 96%, 25g

(R)-1,5-Dimethylpiperazin-2-one, 95.0%, 1g

Tert-butyl n-[2-amino-4-(trifluoromethyl)phenyl]carbamate, 95+%, 100mg

Methyl 2-bromo-3,3-dimethoxypropanoate, 97%, 1g

6-Bromo-1,2-benzisoxazole, 95.0%, 5g

Sel disodique de magnésium EDTA x H2O, min 90 %, pour la synthèse, 250 g, emballage plastique.

Ethyl 7-bromoheptanoate, 98.0%, 1g

4-(4-AMINOPIPERIDINO)PYRIDINE DIHYDROCHLORIDE, 95.0%, 5g

(S)-tert-Butyl 2-(((benzyloxy)carbonyl)amino)-4-hydroxybutanoate, 95%, 100mg